The compound LG283 inhibits bleomycin-induced skin fibrosis via antagonizing TGF-β signaling.
Utsunomiya A, Chino T, Kasamatsu H, Hasegawa T, Utsunomiya N, Luong VH, Matsushita T, Sasaki Y, Ogura D, Niwa SI, Oyama N, Hasegawa M.
Utsunomiya A, et al. Among authors: chino t.
Arthritis Res Ther. 2022 Apr 29;24(1):94. doi: 10.1186/s13075-022-02773-2.
Arthritis Res Ther. 2022.
PMID: 35488265
Free PMC article.